Quick Answer
REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Shares Outstanding of 5.87 million shares for fiscal year 2025.
REVIVA PHARMACEUTICALS HOLDINGS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 5.87M | +148.9% |
| 2024 | 2.36M | -91.5% |
| 2023 | 27.92M | +36.5% |
| 2022 | 20.45M | +41.7% |
| 2021 | 14.43M | +56.3% |
| 2020 | 9.23M | +0.0% |
| 2020 | 9.23M | +241.3% |
| 2020 | 2.70M | +3.9% |
| 2019 | 2.60M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 96.34M | +188.1% | +41.7% |
| June 30, 2025 | 68.00M | +128.1% | +45.5% |
| March 31, 2025 | 46.74M | +67.4% | +0.3% |
| December 31, 2024 | 46.58M | +66.8% | +39.3% |
| September 30, 2024 | 33.44M | +61.9% | +12.2% |
| June 30, 2024 | 29.82M | +31.6% | +6.8% |
| March 31, 2024 | 27.92M | +36.5% | +0.0% |
| December 31, 2023 | 27.92M | +36.5% | +35.2% |
- REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +148.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, REVIVA PHARMACEUTICALS HOLDINGS, INC.’s shares outstanding has grown by 125.7% (from 2.60 million shares to 5.87 million shares).
- The most recent figure is from REVIVA PHARMACEUTICALS HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: